Cargando…

Chronic fatigue syndrome : risk factors, management and impacts on daily life /

Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME) has no clear aetiology, and is defined as severe and chronic fatigue that has lasted for more than six consecutive months, which is not due to physical exertion or other medical conditions associated with fatigue. CFS patients may suff...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Hudson, Connor (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, Incorporated, [2014]
Colección:Neuroscience research progress series.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn893206516
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 140829t20142014nyua ob 001 0 eng
010 |a  2020688408 
040 |a DLC  |b eng  |e rda  |e pn  |c DLC  |d OCLCF  |d D6H  |d AGLDB  |d VTS  |d STF  |d YDX  |d M8D  |d VLY  |d N$T  |d E7B  |d EBLCP  |d YDXCP  |d AU@  |d OCLCO  |d OCL  |d OCLCA  |d OCLCO  |d OCLCQ 
019 |a 893673233  |a 904984451  |a 992841500 
020 |a 9781604569667  |q (ebook) 
020 |a 1604569662 
020 |z 1633219615 
020 |z 9781633219618 
029 1 |a AU@  |b 000056024146 
029 1 |a DEBBG  |b BV042795551 
029 1 |a DEBBG  |b BV043783128 
029 1 |a DEBSZ  |b 472849492 
035 |a (OCoLC)893206516  |z (OCoLC)893673233  |z (OCoLC)904984451  |z (OCoLC)992841500 
042 |a pcc 
050 0 0 |a RB150.F37 
060 4 |a WB 146 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 0 |a 616/.0478  |2 23 
049 |a UAMI 
245 0 0 |a Chronic fatigue syndrome :  |b risk factors, management and impacts on daily life /  |c Connor Hudson, editor. 
264 1 |a New York :  |b Nova Science Publishers, Incorporated,  |c [2014] 
264 4 |c ©2014 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Neuroscience research progress 
500 |a "Nova Biomedical." 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record and cip data provided by publisher. 
505 0 |a ""CHRONIC FATIGUE SYNDROME: RISK FACTORS, MANAGEMENT AND IMPACTS ON DAILY LIFE""; ""CHRONIC FATIGUE SYNDROME: RISK FACTORS, MANAGEMENT AND IMPACTS ON DAILY LIFE""; ""Library of Congress Cataloging-in-Publication Data""; ""Contents""; ""Preface""; ""Chapter I: The Internistâ€?s View on Myalgic Encephalopathy and Complementary/Alternative Treatments""; ""Abstract""; ""Introduction""; ""Pathogenic Concept""; ""The Relation between Pathophysiology and the Clinic""; ""Therapeutic Options""; ""Clinical Experience""; ""Annex""; ""Conclusion and Future Prospects""; ""References"" 
505 8 |a Chapter II: Metal Hypersensitivity As the Cause of Chronic Fatigue Syndrome: Case ReportAbstract -- Introduction -- Conclusion -- References -- Chapter III: Illness Perception and Management in Chronic Fatigue Syndrome -- Abstract -- Introduction -- Illness Perception -- Illness Management -- Conclusion -- Acknowledgment -- References -- Chapter IV: A Review of Current Exercise Management Practices for Chronic Fatigue Syndrome -- Abstract -- 1. Introduction -- 2. Current Management and Treatments for CFS 
505 8 |a 3. The Effects of Chronic Fatigue Syndrome on Exercise Responses4. Exercise Testing and Assessment for Chronic Fatigue Syndrome -- 5. Exercise Prescription and Programming for Chronic Fatigue Syndrome -- 6. Contraindications and Risks for Exercise and Physical Activity -- 7. Patient Needs and Clinical Practice Recommendations -- Conclusion -- References -- Chapter V: Management of Chronic Fatigue Syndrome: Current Approaches and Future Directions -- Abstract -- 1. Introduction -- 2. Proposed Management Strategies -- Conclusion -- References 
505 8 |a Chapter VI: Innate Immune Changes in the Peripheral Blood of Chronic Fatigue Syndrome Patients: Risk Factors for Disease Progression and ManagementAbstract -- Introduction -- Profile of Circulating Leukocytes in SFFV Env Antibody Positive CFS Individuals -- SFFV Env Antibody Positive CFS Patients Have Lower Lymphocyte Percentages -- NKT Cells Are Markedly Increased and NK Cells, Particularly the CD56DIM Cells, Are SignificantlyReduced in SFFV Env Antibody Positive CfsPatients -- The Percentage of CD19+ B Cells Is Reduced inSFFV Env Antibody Positive CFS Patients 
505 8 |a The Percentage of CD19+ B Cells Is Reduced inSFFV Env Antibody Positive CFS PatientsIncreased Activation of Myeloid Derived Cells inSFFV Env Antibody Positive CFS Patients -- Expression of CD69 on CD83+ CD86+ Cells inSFFV Env Antibody Positive CFS Patients IsAssociated with an Activated, Mature DendriticCell Compartment -- Cytokines and Chemokines Are Dysregulated inSFFV Env Antibody Positive Cfs Patients -- Additional Cytokine Signatures in SFFV EnvAntibody Positive CFS Patients Suggest AdditionalTargets and Benefits of Drug Repurposing 
520 |a Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME) has no clear aetiology, and is defined as severe and chronic fatigue that has lasted for more than six consecutive months, which is not due to physical exertion or other medical conditions associated with fatigue. CFS patients may suffer from four or more of the following symptoms: post-exertional malaise lasting for more than 24 hours; tender or swollen lymph nodes; recurring sore throat; unrefreshing sleep; significantly impaired short-term memory and/or concentration; headaches; or joint pain. Management practices have include. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Chronic fatigue syndrome. 
650 0 |a Myalgic encephalomyelitis. 
650 1 2 |a Fatigue Syndrome, Chronic 
650 6 |a Fatigue chronique. 
650 6 |a Encéphalomyélite myalgique. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Myalgic encephalomyelitis.  |2 fast  |0 (OCoLC)fst01031274 
650 7 |a Chronic fatigue syndrome.  |2 fast  |0 (OCoLC)fst00860107 
700 1 |a Hudson, Connor,  |e editor. 
776 0 8 |i Print version:  |t Chronic fatigue syndrome.  |d New York : Nova Science Publishers, Inc., [2014]  |z 1633219615  |w (DLC) 2014949878 
830 0 |a Neuroscience research progress series. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=863047  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL2097173 
938 |a ebrary  |b EBRY  |n ebr10951472 
938 |a EBSCOhost  |b EBSC  |n 863047 
938 |a YBP Library Services  |b YANK  |n 2848207 
994 |a 92  |b IZTAP